These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 7498975)

  • 41. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement.
    Fitscha P; Meisner W
    Blood Press Suppl; 1994; 1():36-9. PubMed ID: 8205296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of results of daily blood pressure self-monitoring and general practice monitoring within the scope of a study assessing treatment of hypertension with quinapril].
    Magometschnigg D; Havelec L; Schnögl H; Deischler H; Fiedler L; Harpf H; Kindermann T; Neumüller M; Pap S; Spitzer D
    Wien Med Wochenschr; 1992; 142(22):501-12. PubMed ID: 1290245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension.
    Jones-Burton C; Rubino J; Roy S; Mai Y; Meehan A; Bellet M; Feig P
    J Am Soc Hypertens; 2010; 4(5):219-26. PubMed ID: 20705534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.
    Neutel JM; Kereiakes DJ; Waverczak WF; Stoakes KA; Xu J; Shojaee A
    Curr Med Res Opin; 2010 Mar; 26(3):721-8. PubMed ID: 20085534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood pressure differences between home monitoring and daytime ambulatory values and their reproducibility in treated hypertensive stroke and TIA patients.
    Davison WJ; Myint PK; Clark AB; Potter JF
    Am Heart J; 2019 Jan; 207():58-65. PubMed ID: 30415084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term and long-term effects of benazepril in mild to moderate hypertensives.
    Chen CH; Hsu TL; Lin SJ; Ting CT; Chou P; Wang SP; Yin FC; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):12-22. PubMed ID: 7553405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators.
    Staessen JA; Byttebier G; Buntinx F; Celis H; O'Brien ET; Fagard R
    JAMA; 1997 Oct; 278(13):1065-72. PubMed ID: 9315764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
    Alli C; Lombardo M; Zanni D; Agrati AM; Cassani M; Granata S
    Am J Hypertens; 1996 Nov; 9(11):1068-76. PubMed ID: 8931831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of angiotensin II type I receptor A1166C polymorphism on benazepril action in hypertensive patients: a family-based association test study.
    Zhang N; Cui H; Yang L
    Arch Pharm Res; 2012 Oct; 35(10):1817-22. PubMed ID: 23139134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does the antihypertensive response to angiotensin converting enzyme inhibition predict the antihypertensive response to angiotensin receptor antagonism?
    Stergiou GS; Skeva II; Baibas NM; Kalkana CB; Roussias LG; Mountokalakis TD
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):688-93. PubMed ID: 11465654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of benazepril on stress testing blood pressure in essential hypertension.
    Cardillo C; Mores N; Motolese M; Folli G
    Am J Cardiol; 1994 Feb; 73(5):368-73. PubMed ID: 8109551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive efficacy of lisinopril. Ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schwartz GL; Schirger A; Ilstrup DM; Long CR; Carlson CA
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):274S-279S. PubMed ID: 2843199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.